Dental tech developer Sonendo said today it closed a $35 million equity financing round with funds slated to support the commercialization of its GentleWave alternative root canal treatment system.
The round was led by newly vested DiNovA Capital and Henry Crown & Company affiliate CVF, and joined by existing investors Fjord Ventures, OrbiMed Advisors, Meritech Capital Partners, NeoMed Management and SEB Private Equity.
As part of the funding round, DiNovA Capital’s Michael Zhao has joined Sonendo’s board of directors, the company said.
“Sonendo’s GentleWave System is uniquely positioned to transform endodontic therapy by delivering exponential improvements in clinical efficacy. DiNovA Capital is pleased to join Sonendo’s existing investors and we look forward to supporting the management and employees of Sonendo in bringing this exciting, innovative product to patients,” Zhao said in prepared remarks.
“With DiNovA Capital and CVF, LLC, we are pleased to expand our top-tier syndicate of committed, long-term investors who recognize the significant potential of this breakthrough technology. Proceeds from this financing will provide the critical resources to support the growth of our commercialization efforts of the GentleWave system as well as continuing our development activities in furthering our Multisonic Ultracleaning technology platform. Our investors share our passion for helping dentists deliver significant, patient-centric, improvements in clinical efficacy and treatment efficiency as we continue to live up to our mission of saving teeth through sound science,” Sonendo prez & CEO Bjarne Bergheim said in a press release.